MedTrace Logo

Effect of Male Circumcision on HIV Incidence (ANRS 1265)

NCT00122525 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 3274

Last updated 2009-04-30

No results posted yet for this study

Summary

Observational studies suggest that male circumcision may provide protection against HIV-1 infection. A randomized, controlled, intervention trial was conducted in a general population of South Africa to test this hypothesis.

Conditions

  • HIV Infections
  • Herpes Genitalis
  • Venereal Diseases

Interventions

PROCEDURE

Male Circumcision

Sponsors & Collaborators

  • French National Agency for Research on AIDS and Viral Hepatitis

    lead OTHER_GOV

Principal Investigators

  • Bertran Auvert, MD · Hôpital Ambroise-Paré (AP-HP); Inserm U687

  • Adrian Puren · NICD, Johannesburg, South Africa

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
24 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2002-07-31
Completion
2005-07-31

Countries

  • South Africa

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00122525 on ClinicalTrials.gov